What: Although not an officially recognized condition, Cosmo UK details accounts from women experiencing long‐term effects after stopping hormonal contraception.
Key line: [Details not provided].
Source: Cosmopolitan UK.
What: Although not an officially recognized condition, Cosmo UK details accounts from women experiencing long‐term effects after stopping hormonal contraception.
Key line: [Details not provided].
Source: Cosmopolitan UK.
A review of over 90,000 drug trials shows that pregnant women are almost entirely excluded.
ProPublica’s review of Texas hospital data reveals a more than 50% increase in sepsis rates among pregnant women after abortion was banned.
Profiles reveal that women in states with strict abortion bans are avoiding pregnancy for fear of inadequate health care.
Beyond recreation, cannabis is being evaluated for therapeutic benefits in women’s care.
Exclusive subscriber content: a comprehensive report on upcoming shifts in women’s health and a 2024 stories database.
The New York Times investigates whether testosterone therapy could benefit menopausal women.
A New York physician faces indictment in Louisiana for prescribing abortion pills.
An Associated Press overview details how various states are introducing bills to criminalize women for obtaining abortion pills.
A small randomized‐control trial found semaglutide cut drinking by 40% in people with alcohol use disorder.
The New York Times examines how Medicaid cuts are critical to funding Republican tax cut plans and underscores the program’s essential role in women’s health.
A federal judge stopped Trump’s move to freeze federal funding that supports essential health programs.
A University of Michigan study finds that women are 60% more likely than men to develop infections following heart surgery.
A marijuana business trade publication reports that some producers are eyeing cannabis-based treatments for women’s health issues.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
KFF Health News reports a woman was billed over $14,000 for an IUD she thought was covered by insurance.
A retrospective study found that preconception use of GLP-1 medications was associated with reduced risks of several adverse pregnancy outcomes.
An analysis of five years of U.S. maternal mortality data reveals significant state-to-state differences in causes of death.
The debate over rebranding early-stage cancers like DCIS aims to reduce patient anxiety.
RFK Jr. demonstrated uncertainty over Medicare fundamentals during his nomination hearing.
Employers are responding to rising fertility costs by increasing access to preconception care, according to new research.